Loading prices…
🔥BULLISH

Injective Could Gain 5–10x in Three Years, Canary CEO Says

Steven McClurg sees institutional demand, tokenization and a shift toward established protocols reshaping crypto's next cycle, while warning that recession risks remain.

Canary Capital CEO Steven McClurg said he sees Injective potentially gaining 5 to 10 times over the next three years, as investors recognize its work and it gains ground on larger-cap projects. He called Injective his top altcoin pick and said he does not hold Ethereum, favoring faster networks such as Injective and Solana.

Why it matters

McClurg described crypto as entering a more institutional phase, with altcoin performance increasingly tied to whether protocols attract financial firms, ETF demand or digital asset treasury buyers. He expects larger-cap, institutionally supported altcoins to lead, while many smaller projects without those buyers may struggle. He pointed to tokenization as a growing area of interest for banks and asset managers, while cautioning that putting assets on a blockchain does not automatically bring them buyers or distribution.

He also said Canary has filed for an Injective ETF, but did not say the product had been approved. His broader picks included XRP Ledger, Hedera, Injective, Sui and Solana. McClurg identified Zcash and Litecoin as privacy-related contenders, arguing that Zcash currently leads the privacy space and that Litecoin could benefit from greater use of its Mimblewimble privacy feature.

Market impact

The outlook is bullish but selective. McClurg expects Bitcoin to rise to between $150,000 and $180,000 over three years, describing that as roughly a double from the level discussed in the interview. He said sophisticated buyers selling call options could dampen volatility and limit upside compared with earlier cycles. For privacy coins, he suggested Litecoin could gain three to five times if Bitcoin doubles, while Zcash could rise four times or more.

He also warned that recession risks, persistent inflation and higher borrowing costs could weigh on households and markets. On crypto's own risks, he pointed to digital asset treasuries that may become forced sellers. His forecast is that crypto can finish the year higher after midterm-related uncertainty passes, but with a less explosive cycle and greater separation between established protocols and weaker altcoins.

Related tokens
$INJ $ZEC $LTC $BTC $XRP

Frequently asked questions

  1. Why does Steven McClurg favor Injective?

    McClurg cited its team, development and focus on integration with Wall Street. He said he sees potential for Injective to gain ground on larger-cap projects.

  2. What kind of altcoins does McClurg expect to lead this cycle?

    He expects larger-cap projects with institutional buyers, ETF access or digital asset treasury support to lead. He said many smaller altcoins without an institutional bid may struggle.

  3. What does McClurg expect for Bitcoin over the next three years?

    He put Bitcoin's potential range at $150,000 to $180,000, describing that as roughly a double from the level discussed in the interview.

  4. What risks did McClurg identify for crypto markets?

    He said recession, persistent inflation and higher borrowing costs concern him. He also warned that some digital asset treasuries could become forced sellers.

  5. What is McClurg's view on tokenization?

    He said banks and asset managers are building tokenization strategies, but moving an asset on-chain does not automatically create distribution or buyers.

Source attribution
Aggregated from Altcoin Daily · Verified · Last refreshed 1h ago
Open original →
Original content